25 XP   0   0   10

ESSA Pharma Inc
Buy, Hold or Sell?

Let's analyse ESSA Pharma Inc together

PenkeI guess you are interested in ESSA Pharma Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ESSA Pharma Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ESSA Pharma Inc

I send you an email if I find something interesting about ESSA Pharma Inc.

Quick analysis of ESSA Pharma Inc (30 sec.)










What can you expect buying and holding a share of ESSA Pharma Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.18
Expected worth in 1 year
$2.70
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$-0.48
Return On Investment
-7.5%

For what price can you sell your share?

Current Price per Share
$6.40
Expected price per share
$5.01 - $8.5
How sure are you?
50%

1. Valuation of ESSA Pharma Inc (5 min.)




Live pricePrice per Share (EOD)

$6.40

Intrinsic Value Per Share

$-7.35 - $-5.80

Total Value Per Share

$-4.17 - $-2.62

2. Growth of ESSA Pharma Inc (5 min.)




Is ESSA Pharma Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$140.6m$169.8m-$21.6m-14.6%

How much money is ESSA Pharma Inc making?

Current yearPrevious yearGrowGrow %
Making money-$6.4m-$8.1m$1.7m26.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of ESSA Pharma Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#316 / 1011

Most Revenue
#968 / 1011

Most Profit
#466 / 1011

Most Efficient
#393 / 1011

What can you expect buying and holding a share of ESSA Pharma Inc? (5 min.)

Welcome investor! ESSA Pharma Inc's management wants to use your money to grow the business. In return you get a share of ESSA Pharma Inc.

What can you expect buying and holding a share of ESSA Pharma Inc?

First you should know what it really means to hold a share of ESSA Pharma Inc. And how you can make/lose money.

Speculation

The Price per Share of ESSA Pharma Inc is $6.4. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of ESSA Pharma Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in ESSA Pharma Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.18. Based on the TTM, the Book Value Change Per Share is $-0.12 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.14 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of ESSA Pharma Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.13-2.1%-0.15-2.3%-0.19-2.9%-0.15-2.4%-0.11-1.8%
Usd Book Value Change Per Share-0.11-1.7%-0.12-1.9%-0.14-2.3%0.152.4%0.081.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.11-1.7%-0.12-1.9%-0.14-2.3%0.152.4%0.081.2%
Usd Price Per Share6.60-3.84-3.42-7.63-4.97-
Price to Earnings Ratio-12.24--6.77--4.39--12.92--5.78-
Price-to-Total Gains Ratio-59.05--32.85--22.63--47.96-146.31-
Price to Book Ratio2.08-1.16-0.88-13.67-15.94-
Price-to-Total Gains Ratio-59.05--32.85--22.63--47.96-146.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.4
Number of shares156
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.120.15
Usd Total Gains Per Share-0.120.15
Gains per Quarter (156 shares)-18.8123.61
Gains per Year (156 shares)-75.2494.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-75-8509484
20-150-1600189178
30-226-2350283272
40-301-3100378366
50-376-3850472460
60-451-4600567554
70-527-5350661648
80-602-6100756742
90-677-6850850836
100-752-7600944930

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%3.037.00.07.5%3.038.01.07.1%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%11.027.02.027.5%12.027.03.028.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.042.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%11.027.02.027.5%12.027.03.028.6%

Fundamentals of ESSA Pharma Inc

About ESSA Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Fundamental data was last updated by Penke on 2024-04-11 07:00:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of ESSA Pharma Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ESSA Pharma Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare ESSA Pharma Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ESSA Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-48,813.4%+48,813.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--196.1%+196.1%
TTM--211.9%+211.9%
YOY--277.7%+277.7%
5Y--432.9%+432.9%
10Y-48,813.4%-599.3%-48,214.1%
1.1.2. Return on Assets

Shows how efficient ESSA Pharma Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ESSA Pharma Inc to the Biotechnology industry mean.
  • -4.1% Return on Assets means that ESSA Pharma Inc generated $-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ESSA Pharma Inc:

  • The MRQ is -4.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.1%TTM-4.3%+0.1%
TTM-4.3%YOY-4.7%+0.4%
TTM-4.3%5Y-9.9%+5.7%
5Y-9.9%10Y-20.6%+10.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.1%-13.3%+9.2%
TTM-4.3%-12.7%+8.4%
YOY-4.7%-11.8%+7.1%
5Y-9.9%-14.0%+4.1%
10Y-20.6%-15.9%-4.7%
1.1.3. Return on Equity

Shows how efficient ESSA Pharma Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ESSA Pharma Inc to the Biotechnology industry mean.
  • -4.2% Return on Equity means ESSA Pharma Inc generated $-0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ESSA Pharma Inc:

  • The MRQ is -4.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.2%TTM-4.3%+0.1%
TTM-4.3%YOY-4.8%+0.4%
TTM-4.3%5Y-37.3%+33.0%
5Y-37.3%10Y-48.2%+10.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.2%-16.9%+12.7%
TTM-4.3%-16.0%+11.7%
YOY-4.8%-15.1%+10.3%
5Y-37.3%-19.7%-17.6%
10Y-48.2%-20.5%-27.7%

1.2. Operating Efficiency of ESSA Pharma Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ESSA Pharma Inc is operating .

  • Measures how much profit ESSA Pharma Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ESSA Pharma Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ESSA Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-59,949.1%+59,949.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--290.9%+290.9%
TTM--224.4%+224.4%
YOY--288.3%+288.3%
5Y--479.5%+479.5%
10Y-59,949.1%-625.2%-59,323.9%
1.2.2. Operating Ratio

Measures how efficient ESSA Pharma Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of ESSA Pharma Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y597.811-597.811
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.110-3.110
TTM-3.266-3.266
YOY-3.783-3.783
5Y-5.657-5.657
10Y597.8117.783+590.028

1.3. Liquidity of ESSA Pharma Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if ESSA Pharma Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 40.75 means the company has $40.75 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of ESSA Pharma Inc:

  • The MRQ is 40.746. The company is very able to pay all its short-term debts. +2
  • The TTM is 50.541. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ40.746TTM50.541-9.795
TTM50.541YOY55.365-4.824
TTM50.5415Y43.670+6.871
5Y43.67010Y23.317+20.353
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ40.7463.905+36.841
TTM50.5414.212+46.329
YOY55.3655.337+50.028
5Y43.6706.062+37.608
10Y23.3176.401+16.916
1.3.2. Quick Ratio

Measures if ESSA Pharma Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ESSA Pharma Inc to the Biotechnology industry mean.
  • A Quick Ratio of 70.54 means the company can pay off $70.54 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ESSA Pharma Inc:

  • The MRQ is 70.542. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 74.273. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ70.542TTM74.273-3.731
TTM74.273YOY77.348-3.075
TTM74.2735Y56.006+18.267
5Y56.00610Y29.388+26.618
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ70.5423.572+66.970
TTM74.2734.001+70.272
YOY77.3485.364+71.984
5Y56.0066.009+49.997
10Y29.3886.287+23.101

1.4. Solvency of ESSA Pharma Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ESSA Pharma Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ESSA Pharma Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.03 means that ESSA Pharma Inc assets are financed with 2.6% credit (debt) and the remaining percentage (100% - 2.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ESSA Pharma Inc:

  • The MRQ is 0.026. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.021. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.026TTM0.021+0.005
TTM0.021YOY0.019+0.002
TTM0.0215Y0.101-0.080
5Y0.10110Y0.439-0.338
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0260.336-0.310
TTM0.0210.334-0.313
YOY0.0190.271-0.252
5Y0.1010.366-0.265
10Y0.4390.389+0.050
1.4.2. Debt to Equity Ratio

Measures if ESSA Pharma Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ESSA Pharma Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 2.7% means that company has $0.03 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ESSA Pharma Inc:

  • The MRQ is 0.027. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.022. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.027TTM0.022+0.005
TTM0.022YOY0.020+0.002
TTM0.0225Y0.628-0.606
5Y0.62810Y1.001-0.373
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0270.382-0.355
TTM0.0220.397-0.375
YOY0.0200.341-0.321
5Y0.6280.432+0.196
10Y1.0010.465+0.536

2. Market Valuation of ESSA Pharma Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings ESSA Pharma Inc generates.

  • Above 15 is considered overpriced but always compare ESSA Pharma Inc to the Biotechnology industry mean.
  • A PE ratio of -12.24 means the investor is paying $-12.24 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ESSA Pharma Inc:

  • The EOD is -11.867. Based on the earnings, the company is expensive. -2
  • The MRQ is -12.238. Based on the earnings, the company is expensive. -2
  • The TTM is -6.766. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.867MRQ-12.238+0.371
MRQ-12.238TTM-6.766-5.472
TTM-6.766YOY-4.390-2.376
TTM-6.7665Y-12.919+6.152
5Y-12.91910Y-5.782-7.136
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-11.867-2.262-9.605
MRQ-12.238-2.599-9.639
TTM-6.766-2.674-4.092
YOY-4.390-4.133-0.257
5Y-12.919-6.258-6.661
10Y-5.782-6.171+0.389
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ESSA Pharma Inc:

  • The EOD is -10.429. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.755. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.015. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.429MRQ-10.755+0.326
MRQ-10.755TTM-8.015-2.740
TTM-8.015YOY-5.384-2.631
TTM-8.0155Y-15.619+7.603
5Y-15.61910Y-11.628-3.991
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.429-2.913-7.516
MRQ-10.755-3.275-7.480
TTM-8.015-3.508-4.507
YOY-5.384-5.620+0.236
5Y-15.619-8.306-7.313
10Y-11.628-8.854-2.774
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ESSA Pharma Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.08 means the investor is paying $2.08 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of ESSA Pharma Inc:

  • The EOD is 2.012. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.075. Based on the equity, the company is underpriced. +1
  • The TTM is 1.162. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.012MRQ2.075-0.063
MRQ2.075TTM1.162+0.913
TTM1.162YOY0.878+0.284
TTM1.1625Y13.667-12.504
5Y13.66710Y15.940-2.273
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.0121.858+0.154
MRQ2.0752.090-0.015
TTM1.1622.091-0.929
YOY0.8782.866-1.988
5Y13.6673.488+10.179
10Y15.9403.836+12.104
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of ESSA Pharma Inc.

3.1. Institutions holding ESSA Pharma Inc

Institutions are holding 78.657% of the shares of ESSA Pharma Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Bvf Inc19.77620.729874862900
2023-12-31Bellevue Group AG17.85470.7974789858300
2023-12-31Soleus Capital Management, L.P.9.78263.16924327622405280.9453
2023-09-30Partner Fund Management LP9.49240.61134199253-5700-0.1356
2023-12-31Morgan Stanley - Brokerage Accounts9.46370.0024418657838950.0931
2023-12-31RTW INVESTMENTS, LLC5.19610.237229866222986620
2023-12-31Adage Capital Partners Gp LLC2.56780.01551135931934008.959
2023-12-31HHG PLC2.46280.0043108948210894820
2023-12-31Rock Springs Capital Management LP1.53040.1167700500
2023-12-31Rhenman Partners Asset Management AB0.80590.235135650000
2023-09-30D. E. Shaw & Co LP0.37990.000516805000
2023-12-31CIBC World Markets Inc.0.25250.0019111700-37443-25.1054
2023-12-31BNP Paribas Arbitrage, SA0.12990.00045746635771164.8813
2023-12-31Royal Bank of Canada0.06960.000130775292771954.4059
2023-12-31Geode Capital Management, LLC0.0607026858781941.0683
2023-12-31Renaissance Technologies Corp0.05480.000324234242340
2023-12-31American Century Companies Inc0.04530.000120044200440
2023-12-31Privium Fund Management (UK) Ltd0.04530.08982003200
2023-12-31Group One Trading, LP0.02530.000211175-30685-73.3039
2023-12-31BlackRock Inc0.01740767700
Total 80.01336.004535396256+3569284+10.1%

3.2. Funds holding ESSA Pharma Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30BB Biotech AG Ord17.81170.9968787958300
2023-11-30Rhenman Healthcare Equity L/S RC2 SEK0.80590.220235650000
2024-01-31Fidelity Nasdaq Composite Index0.06070.00152685800
2024-02-29Avantis US Small Cap Equity ETF0.05670.02812510100
2023-06-30Bellevue (Lux) Bellevue Glbl Mac I EUR0.04290.0461900000
2023-12-31NT Quality Small Cap Core0.00580.0072549-187-6.8348
2023-12-31NT Quality SCC US Fund - L0.00580.00672549-187-6.8348
2023-09-30Blackstone Alternative Multi-Strategy I0.00180.0001800-300-27.2727
Total 18.79131.30648312940-6740.0%

3.3. Insider Transactions

Insiders are holding 2.271% of the shares of ESSA Pharma Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-05Peter VirsikSELL6947.94
2024-03-05Peter VirsikSELL6948.98
2024-01-16Peter VirsikSELL171810.01
2024-01-05Peter VirsikSELL6996.11
2023-12-14David Ross ParkinsonBUY92232.3
2023-11-21Franklin M BergerBUY232595.73
2023-11-02Franklin M BergerBUY600005.35

4. Summary

4.1. Key Performance Indicators

The key performance indicators of ESSA Pharma Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.112-0.121+8%-0.144+29%0.151-174%0.079-241%
Book Value Per Share--3.1803.351-5%3.839-17%2.700+18%1.382+130%
Current Ratio--40.74650.541-19%55.365-26%43.670-7%23.317+75%
Debt To Asset Ratio--0.0260.021+23%0.019+37%0.101-74%0.439-94%
Debt To Equity Ratio--0.0270.022+24%0.020+38%0.628-96%1.001-97%
Dividend Per Share----0%-0%-0%-0%
Eps---0.135-0.147+9%-0.185+37%-0.154+14%-0.113-16%
Free Cash Flow Per Share---0.153-0.122-21%-0.158+3%-0.122-20%-0.095-38%
Free Cash Flow To Equity Per Share---0.149-0.121-19%-0.157+5%0.144-203%0.080-287%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---5.801--------
Intrinsic Value_10Y_min---7.345--------
Intrinsic Value_1Y_max---0.408--------
Intrinsic Value_1Y_min---0.609--------
Intrinsic Value_3Y_max---1.358--------
Intrinsic Value_3Y_min---1.951--------
Intrinsic Value_5Y_max---2.467--------
Intrinsic Value_5Y_min---3.414--------
Market Cap283123840.000-3%291971460.000169874304.000+72%151183706.750+93%337555283.002-14%220015425.469+33%
Net Profit Margin----0%-0%-0%-488.1340%
Operating Margin----0%-0%-0%-599.4910%
Operating Ratio----0%-0%-0%597.811-100%
Pb Ratio2.012-3%2.0751.162+79%0.878+136%13.667-85%15.940-87%
Pe Ratio-11.867+3%-12.238-6.766-45%-4.390-64%-12.919+6%-5.782-53%
Price Per Share6.400-3%6.6003.840+72%3.418+93%7.630-14%4.973+33%
Price To Free Cash Flow Ratio-10.429+3%-10.755-8.015-25%-5.384-50%-15.619+45%-11.628+8%
Price To Total Gains Ratio-57.265+3%-59.054-32.848-44%-22.628-62%-47.958-19%146.310-140%
Quick Ratio--70.54274.273-5%77.348-9%56.006+26%29.388+140%
Return On Assets---0.041-0.043+3%-0.047+14%-0.099+141%-0.206+399%
Return On Equity---0.042-0.043+2%-0.048+13%-0.373+781%-0.482+1037%
Total Gains Per Share---0.112-0.121+8%-0.144+29%0.151-174%0.079-241%
Usd Book Value--140682939.000148222636.750-5%169842165.500-17%119448128.600+18%61148904.194+130%
Usd Book Value Change Per Share---0.112-0.121+8%-0.144+29%0.151-174%0.079-241%
Usd Book Value Per Share--3.1803.351-5%3.839-17%2.700+18%1.382+130%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.135-0.147+9%-0.185+37%-0.154+14%-0.113-16%
Usd Free Cash Flow---6787003.000-5393491.500-21%-6969818.000+3%-5403544.150-20%-4180884.552-38%
Usd Free Cash Flow Per Share---0.153-0.122-21%-0.158+3%-0.122-20%-0.095-38%
Usd Free Cash Flow To Equity Per Share---0.149-0.121-19%-0.157+5%0.144-203%0.080-287%
Usd Market Cap283123840.000-3%291971460.000169874304.000+72%151183706.750+93%337555283.002-14%220015425.469+33%
Usd Price Per Share6.400-3%6.6003.840+72%3.418+93%7.630-14%4.973+33%
Usd Profit---5964322.000-6451386.000+8%-8166688.750+37%-6777670.800+14%-4443497.912-25%
Usd Revenue----0%-0%-0%5.425-100%
Usd Total Gains Per Share---0.112-0.121+8%-0.144+29%0.151-174%0.079-241%
 EOD+3 -5MRQTTM+14 -15YOY+19 -105Y+13 -1610Y+15 -16

4.2. Fundamental Score

Let's check the fundamental score of ESSA Pharma Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-11.867
Price to Book Ratio (EOD)Between0-12.012
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than170.542
Current Ratio (MRQ)Greater than140.746
Debt to Asset Ratio (MRQ)Less than10.026
Debt to Equity Ratio (MRQ)Less than10.027
Return on Equity (MRQ)Greater than0.15-0.042
Return on Assets (MRQ)Greater than0.05-0.041
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of ESSA Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5027.839
Ma 20Greater thanMa 507.863
Ma 50Greater thanMa 1008.580
Ma 100Greater thanMa 2007.913
OpenGreater thanClose6.320
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets144,489
Total Liabilities3,806
Total Stockholder Equity140,683
 As reported
Total Liabilities 3,806
Total Stockholder Equity+ 140,683
Total Assets = 144,489

Assets

Total Assets144,489
Total Current Assets143,869
Long-term Assets620
Total Current Assets
Cash And Cash Equivalents 35,345
Short-term Investments 106,775
Net Receivables 181
Other Current Assets 1,568
Total Current Assets  (as reported)143,869
Total Current Assets  (calculated)143,869
+/-0
Long-term Assets
Property Plant Equipment 363
Long-term Assets Other 257
Long-term Assets  (as reported)620
Long-term Assets  (calculated)620
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,531
Long-term Liabilities275
Total Stockholder Equity140,683
Total Current Liabilities
Short-term Debt 99
Accounts payable 2,600
Other Current Liabilities 831
Total Current Liabilities  (as reported)3,531
Total Current Liabilities  (calculated)3,531
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt275
Long-term Liabilities  (as reported)275
Long-term Liabilities  (calculated)275
+/-0
Total Stockholder Equity
Common Stock278,511
Retained Earnings -185,426
Accumulated Other Comprehensive Income -2,100
Other Stockholders Equity 49,697
Total Stockholder Equity (as reported)140,683
Total Stockholder Equity (calculated)140,683
+/-0
Other
Capital Stock278,511
Cash and Short Term Investments 142,120
Common Stock Shares Outstanding 44,129
Liabilities and Stockholders Equity 144,489
Net Debt -34,970
Net Invested Capital 140,683
Net Working Capital 140,338
Property Plant and Equipment Gross 363
Short Long Term Debt Total 375



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-30
> Total Assets 
657
0
0
0
4,202
3,981
10,969
7,793
7,495
4,623
17,471
13,667
10,402
15,981
13,739
8,406
5,607
3,433
22,334
18,512
16,017
13,215
9,612
7,072
54,774
47,364
41,795
38,287
80,575
76,175
210,001
203,524
198,166
191,486
182,609
175,661
169,505
165,003
158,504
153,650
149,122
144,489
144,489149,122153,650158,504165,003169,505175,661182,609191,486198,166203,524210,00176,17580,57538,28741,79547,36454,7747,0729,61213,21516,01718,51222,3343,4335,6078,40613,73915,98110,40213,66717,4714,6237,4957,79310,9693,9814,202000657
   > Total Current Assets 
0
0
0
0
3,827
3,569
10,585
7,362
7,048
4,012
17,054
13,267
10,402
15,609
13,379
8,057
5,607
2,685
22,017
18,289
16,017
12,799
9,104
5,322
54,774
47,364
41,219
37,744
80,575
76,175
209,382
202,958
197,598
190,949
182,102
175,184
169,505
164,588
158,504
153,290
148,797
143,869
143,869148,797153,290158,504164,588169,505175,184182,102190,949197,598202,958209,38276,17580,57537,74441,21947,36454,7745,3229,10412,79916,01718,28922,0172,6855,6078,05713,37915,60910,40213,26717,0544,0127,0487,36210,5853,5693,8270000
       Cash And Cash Equivalents 
225
0
0
0
3,700
3,446
10,442
6,235
1,570
2,609
15,933
12,379
8,985
10,859
12,619
7,329
3,957
1,868
21,692
18,062
14,829
12,174
8,598
4,874
53,323
45,934
39,914
36,482
56,321
52,485
151,562
145,194
137,825
121,058
86,236
67,868
57,076
51,221
44,301
38,467
33,702
35,345
35,34533,70238,46744,30151,22157,07667,86886,236121,058137,825145,194151,56252,48556,32136,48239,91445,93453,3234,8748,59812,17414,82918,06221,6921,8683,9577,32912,61910,8598,98512,37915,9332,6091,5706,23510,4423,4463,700000225
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,011
22,016
57,035
57,069
57,102
68,141
94,783
106,728
110,161
111,851
112,743
114,002
114,374
106,775
106,775114,374114,002112,743111,851110,161106,72894,78368,14157,10257,06957,03522,01622,0110000000000000000000000000000
       Net Receivables 
0
0
0
0
65
61
88
38
3,827
41
39
30
16
4,018
100
14
29
24
59
56
297
248
244
275
361
350
350
349
310
231
293
231
489
2
19
19
6
15
9
133
135
181
18113513391561919248923129323131034935035036127524424829756592429141004,018163039413,827388861650000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
-16
0
0
0
-29
0
0
0
420
0
0
0
-361
0
0
0
-310
-231
0
0
0
0
0
0
110,607
0
-9
0
0
0
000-90110,607000000-231-310000-361000420000-29000-16000000000000
   > Long-term Assets 
0
0
0
0
375
412
384
431
447
610
417
400
383
372
360
349
548
748
317
224
420
416
508
1,750
475
0
576
544
278
278
619
566
568
537
507
476
446
416
126
360
325
620
62032536012641644647650753756856661927827854457604751,7505084164202243177485483493603723834004176104474313844123750000
       Property Plant Equipment 
0
0
0
0
14
69
75
120
164
156
152
140
128
121
114
107
100
94
89
0
0
0
0
0
0
138
110
83
55
28
341
298
308
278
247
217
186
156
126
95
68
363
363689512615618621724727830829834128558311013800000089941001071141211281401521561641207569140000
       Intangible Assets 
417
0
0
0
361
343
309
311
282
269
265
260
256
251
246
242
237
233
228
224
219
214
210
205
201
196
192
187
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000187192196201205210214219224228233237242246251256260265269282311309343361000417
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
185
0
0
0
0
0
0
211
421
0
0
201
201
298
1,545
274
0
274
274
222
250
278
269
259
259
259
259
259
259
0
265
257
257
257257265025925925925925925926927825022227427402741,54529820120100421211000000185000000000
> Total Liabilities 
178
0
0
0
2,228
972
2,052
3,407
3,066
3,954
10,587
10,403
10,939
14,511
19,638
10,584
9,881
9,751
8,960
7,574
6,865
6,437
5,948
6,453
5,593
1,334
1,517
1,352
1,331
2,074
4,593
3,826
4,160
3,947
3,894
4,145
2,387
2,983
2,166
3,408
3,495
3,806
3,8063,4953,4082,1662,9832,3874,1453,8943,9474,1603,8264,5932,0741,3311,3521,5171,3345,5936,4535,9486,4376,8657,5748,9609,7519,88110,58419,63814,51110,93910,40310,5873,9543,0663,4072,0529722,228000178
   > Total Current Liabilities 
178
0
0
0
2,228
972
2,052
3,407
3,066
3,954
10,587
10,403
3,630
1,481
3,707
3,478
3,777
4,329
4,162
3,439
3,344
3,612
3,733
5,040
5,575
1,228
1,473
1,268
1,204
2,036
3,180
3,009
3,930
3,658
3,749
4,034
2,310
2,935
2,146
3,408
3,495
3,531
3,5313,4953,4082,1462,9352,3104,0343,7493,6583,9303,0093,1802,0361,2041,2681,4731,2285,5755,0403,7333,6123,3443,4394,1624,3293,7773,4783,7071,4813,63010,40310,5873,9543,0663,4072,0529722,228000178
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
7,714
663
1,339
2,027
2,718
2,767
2,818
2,816
2,874
2,864
2,988
3,709
0
115
87
59
30
94
98
121
133
128
131
134
130
125
111
80
99
9980111125130134131128133121989430598711503,7092,9882,8642,8742,8162,8182,7672,7182,0271,3396637,7140000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
7,714
7,799
7,842
2,027
2,718
2,767
2,818
2,816
2,874
2,864
2,988
3,709
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000003,7092,9882,8642,8742,8162,8182,7672,7182,0277,8427,7997,7140000000000000
       Accounts payable 
178
0
0
0
587
674
1,172
1,146
2,096
3,102
1,176
1,860
3,539
1,390
2,953
2,048
1,641
1,501
1,380
621
524
739
869
2,052
1,566
1,010
1,358
1,181
1,144
1,376
1,691
908
1,426
1,563
757
556
955
1,635
1,196
2,051
2,028
2,600
2,6002,0282,0511,1961,6359555567571,5631,4269081,6911,3761,1441,1811,3581,0101,5662,0528697395246211,3801,5011,6412,0482,9531,3903,5391,8601,1763,1022,0961,1461,172674587000178
       Other Current Liabilities 
0
0
0
0
1,640
972
2,052
3,407
3,066
3,954
10,587
10,403
91
91
91
1
109
110
15
0
4
0
3,733
0
300
1,228
0
0
1
630
1,395
2,003
2,383
1,962
2,864
3,347
1,222
1,170
825
1,246
1,386
831
8311,3861,2468251,1701,2223,3472,8641,9622,3832,0031,3956301001,22830003,73304015110109191919110,40310,5873,9543,0663,4072,0529721,6400000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
7,309
13,030
15,931
7,106
6,104
5,422
4,798
4,135
3,521
2,825
2,216
1,413
18
106
44
84
127
38
1,413
818
231
289
145
111
77
48
20
0
0
275
275002048771111452892318181,413381278444106181,4132,2162,8253,5214,1354,7985,4226,1047,10615,93113,0307,309000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,818
2,192
1,405
0
27
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002701,4052,1922,818000000000000000000000
       Other Liabilities 
0
0
0
0
1,641
297
879
2,239
995
588
9,218
8,350
7,310
5,315
8,795
603
171
82
73
40
20
7
23
8
18
79
44
77
127
38
1,166
598
20
120
0
0
0
0
0
0
0
0
00000000120205981,16638127774479188237204073821716038,7955,3157,3108,3509,2185889952,2398792971,6410000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
211
421
0
0
0
0
97
1,545
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,5459700004212110000000000000000
> Total Stockholder Equity
478
0
0
0
1,974
3,009
8,917
4,386
4,429
668
6,884
3,264
-537
1,470
-5,899
-2,178
-4,274
-6,317
13,374
10,939
9,152
6,778
3,664
619
49,181
46,030
40,278
36,936
79,244
74,101
205,408
199,698
194,006
187,539
178,715
171,516
167,118
162,020
156,338
150,243
145,627
140,683
140,683145,627150,243156,338162,020167,118171,516178,715187,539194,006199,698205,40874,10179,24436,93640,27846,03049,1816193,6646,7789,15210,93913,374-6,317-4,274-2,178-5,8991,470-5373,2646,8846684,4294,3868,9173,0091,974000478
   Retained Earnings -185,426-179,461-173,980-166,681-159,621-152,879-146,555-137,728-126,874-117,776-109,216-100,464-87,499-80,970-73,722-68,789-59,433-54,811-53,811-50,510-47,080-44,369-42,093-39,213-34,871-32,964-30,794-34,387-26,776-28,241-24,004-20,138-19,611-13,134-14,768-9,456-6,567-5,9490000
   Accumulated Other Comprehensive Income 
0
0
0
0
893
1,256
1,259
1,488
1,213
813
1,060
1,293
1,729
2,271
2,513
2,636
2,486
2,574
12,386
12,825
13,315
11,511
11,828
5,467
27,780
-2,000
32,437
33,889
-2,076
-2,076
-2,076
-2,076
-2,076
-2,076
-2,125
-2,128
-2,135
-2,106
-2,165
-2,122
-2,120
-2,100
-2,100-2,120-2,122-2,165-2,106-2,135-2,128-2,125-2,076-2,076-2,076-2,076-2,076-2,07633,88932,437-2,00027,7805,46711,82811,51113,31512,82512,3862,5742,4862,6362,5132,2711,7291,2931,0608131,2131,4881,2591,2568930000
   Capital Surplus 000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-118
Gross Profit-118-118
 
Operating Income (+$)
Gross Profit-118
Operating Expense-32,134
Operating Income-26,580-32,253
 
Operating Expense (+$)
Research Development21,323
Selling General Administrative11,366
Selling And Marketing Expenses0
Operating Expense32,13432,689
 
Net Interest Income (+$)
Interest Income5,554
Interest Expense-7
Other Finance Cost-0
Net Interest Income5,547
 
Pretax Income (+$)
Operating Income-26,580
Net Interest Income5,547
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-26,581-26,587
EBIT - interestExpense = -26,587
-26,581
-26,575
Interest Expense7
Earnings Before Interest and Taxes (EBIT)-26,580-26,574
Earnings Before Interest and Taxes (EBITDA)-26,462
 
After tax Income (+$)
Income Before Tax-26,581
Tax Provision-2
Net Income From Continuing Ops-26,582-26,582
Net Income-26,582
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses32,134
Total Other Income/Expenses Net7-5,547
 

Technical Analysis of ESSA Pharma Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of ESSA Pharma Inc. The general trend of ESSA Pharma Inc is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine ESSA Pharma Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ESSA Pharma Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 6.5 < 7.17 < 8.5.

The bearish price targets are: 6.13 > 5.7 > 5.01.

Tweet this
ESSA Pharma Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ESSA Pharma Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ESSA Pharma Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ESSA Pharma Inc. The current macd is -0.5685521.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the ESSA Pharma Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for ESSA Pharma Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the ESSA Pharma Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
ESSA Pharma Inc Daily Moving Average Convergence/Divergence (MACD) ChartESSA Pharma Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ESSA Pharma Inc. The current adx is 21.72.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell ESSA Pharma Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
ESSA Pharma Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ESSA Pharma Inc. The current sar is 7.56374672.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
ESSA Pharma Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ESSA Pharma Inc. The current rsi is 27.84. The current phase is Oversold in neutral market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in neutral market:
  • Trending up: The RSI is trending up. +1
ESSA Pharma Inc Daily Relative Strength Index (RSI) ChartESSA Pharma Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ESSA Pharma Inc. The current phase is Oversold in neutral market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the ESSA Pharma Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
ESSA Pharma Inc Daily Stochastic Oscillator ChartESSA Pharma Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ESSA Pharma Inc. The current cci is -160.8218191.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
ESSA Pharma Inc Daily Commodity Channel Index (CCI) ChartESSA Pharma Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ESSA Pharma Inc. The current cmo is -53.70987987.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
ESSA Pharma Inc Daily Chande Momentum Oscillator (CMO) ChartESSA Pharma Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ESSA Pharma Inc. The current willr is -90.90909091.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
ESSA Pharma Inc Daily Williams %R ChartESSA Pharma Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ESSA Pharma Inc.

ESSA Pharma Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ESSA Pharma Inc. The current atr is 0.65589723.

ESSA Pharma Inc Daily Average True Range (ATR) ChartESSA Pharma Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ESSA Pharma Inc. The current obv is 87,932,171.

ESSA Pharma Inc Daily On-Balance Volume (OBV) ChartESSA Pharma Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ESSA Pharma Inc. The current mfi is 31.12.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
ESSA Pharma Inc Daily Money Flow Index (MFI) ChartESSA Pharma Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ESSA Pharma Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

ESSA Pharma Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ESSA Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5027.839
Ma 20Greater thanMa 507.863
Ma 50Greater thanMa 1008.580
Ma 100Greater thanMa 2007.913
OpenGreater thanClose6.320
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of ESSA Pharma Inc with someone you think should read this too:
  • Are you bullish or bearish on ESSA Pharma Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about ESSA Pharma Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ESSA Pharma Inc

I send you an email if I find something interesting about ESSA Pharma Inc.


Comments

How you think about this?

Leave a comment

Stay informed about ESSA Pharma Inc.

Receive notifications about ESSA Pharma Inc in your mailbox!